Methodology of metabolic risk factor identification in patients with Stage I abdominal obesity

Aim. To study modifiable and non-modifiable risk factors (RF) of Stage I obesity and metabolic disturbances, related to associated pathology development.Material and methods. Seventy-eight men and 54 women, aged 30-50 years, with abdominal-visceral obesity (body mass index 25-35 kg/m2), without card...

Full description

Saved in:
Bibliographic Details
Published inKardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika Vol. 6; no. 1; pp. 79 - 83
Main Authors M. A. Khasina, E. I. Trofimova, T. N. Lemeshko, O. A. Artyukova
Format Journal Article
LanguageRussian
Published SILICEA-POLIGRAF» LLC 01.02.2007
Subjects
абдоминальное ожирение
липиды
сердечно-сосудистые заболевания
факторы риска
Online AccessGet full text

Cover

More Information
Summary:Aim. To study modifiable and non-modifiable risk factors (RF) of Stage I obesity and metabolic disturbances, related to associated pathology development.Material and methods. Seventy-eight men and 54 women, aged 30-50 years, with abdominal-visceral obesity (body mass index 25-35 kg/m2), without cardiovascular disease, underwent questionnaire survey, anthropometry, and blood lipid profile assessment.Results. Eighty per cent of the patients had 9-11 obesity and associated pathology RF, 14% – 4-8 RF, and just 6% – ≤3 RF. Lipid profile disturbances were registered in 92% of men and 89% of women. In men, levels of very lowdensity lipoprotein cholesterol, triglycerides and atherogenicity index were significantly higher. Conclusion. Based on present RF levels, registered in 122 atherosclerosis-free patients with Stage I abdominal obesity, 10-year risk of associated pathology was estimated as moderate (10-20%) in 105 (79%) patients, and mild (5-10%) in 17 (13%) patients.
ISSN:1728-8800
2619-0125